Identifies novel benzimidazole derivatives with potential therapeutic applications.
Benzimidazole is a privileged heterocyclic scaffold known for its diverse pharmacological activities and wide applications in medicinal chemistry. The present study focused on the designing, synthesis, and characterization of 2,2-substituted benzimidazole derivatives. Six novel compounds (RY-1 to RY-6) were successfully synthesized via an efficient, eco-friendly one-pot condensation of o-phenylenediamine with various substituted benzaldehydes using sodium metabisulfite in ethanol. The synthesized derivatives include RY-1 [2-(4-fluorophenyl)-1H-benzo[d]imidazole], RY-2 [2-(4-chlorophenyl)-1H-benzo[d]imidazole], RY-3 [2-(4-bromophenyl)-1H-benzo[d]imidazole], RY-4 [2-(4-methylphenyl)-1H-benzo[d]imidazole], RY-5 [2-(4-methoxyphenyl)-1H-benzo[d]imidazole], and RY-6 [2-(3,4-dichlorophenyl)-1H-benzo[d]imidazole]. All compounds were obtained in good to excellent yields (75–88%) as crystalline solids and were thoroughly characterized by melting point, FT-IR, ¹H-NMR, ¹³C-NMR, and ESI-MS spectral analysis. The spectroscopic data confirmed the successful formation of the benzimidazole ring system. The green synthetic protocol employed offers advantages such as short reaction time, simple work-up, and avoidance of hazardous reagents, making it suitable for pharmaceutical applications. This work provides a series of well-characterized novel 2-substituted benzimidazole derivatives that can serve as promising leads for further biological evaluation against antimicrobial, anticancer, and other therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Ritika1, Ravi Saini2*, Renu Saini2, Dr. Omprakash Goshain2 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: